Mark C. Navin

1.6k total citations
64 papers, 795 citations indexed

About

Mark C. Navin is a scholar working on Health, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark C. Navin has authored 64 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Health, 28 papers in General Health Professions and 25 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark C. Navin's work include Vaccine Coverage and Hesitancy (34 papers), Ethics and Legal Issues in Pediatric Healthcare (25 papers) and Ethics in medical practice (14 papers). Mark C. Navin is often cited by papers focused on Vaccine Coverage and Hesitancy (34 papers), Ethics and Legal Issues in Pediatric Healthcare (25 papers) and Ethics in medical practice (14 papers). Mark C. Navin collaborates with scholars based in United States, Australia and Netherlands. Mark C. Navin's co-authors include Katie Attwell, Mark A. Largent, Jason Adam Wasserman, Aaron M. McCright, Dilshani Sarathchandra, Saad B. Omer, Sabine Reiter, Pier Luigi Lopalco, C. Jestin and Andrea T. Kozak and has published in prestigious journals such as JAMA, PEDIATRICS and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Mark C. Navin

58 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark C. Navin United States 15 508 243 170 158 151 64 795
Irene A. Harmsen Netherlands 15 497 1.0× 120 0.5× 199 1.2× 92 0.6× 188 1.2× 18 859
Emily K. Brunson United States 10 372 0.7× 115 0.5× 187 1.1× 97 0.6× 112 0.7× 25 599
Aglaia Katsiroumpa Greece 16 375 0.7× 216 0.9× 128 0.8× 52 0.3× 220 1.5× 59 793
Robert A. Bednarczyk United States 18 1.0k 2.1× 188 0.8× 373 2.2× 164 1.0× 335 2.2× 62 1.3k
Maryline Vivion Canada 10 918 1.8× 106 0.4× 381 2.2× 98 0.6× 355 2.4× 21 1.1k
Ovidiu Tatar Canada 15 582 1.1× 75 0.3× 228 1.3× 57 0.4× 178 1.2× 36 939
Kyla Thomas United States 12 646 1.3× 102 0.4× 316 1.9× 93 0.6× 300 2.0× 24 946
Ana Gama Portugal 17 578 1.1× 313 1.3× 446 2.6× 57 0.4× 479 3.2× 82 1.3k
Samara Perez Canada 22 1.1k 2.1× 123 0.5× 442 2.6× 111 0.7× 254 1.7× 46 1.6k
Philip M. Massey United States 20 496 1.0× 341 1.4× 503 3.0× 48 0.3× 90 0.6× 62 1.2k

Countries citing papers authored by Mark C. Navin

Since Specialization
Citations

This map shows the geographic impact of Mark C. Navin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Navin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Navin more than expected).

Fields of papers citing papers by Mark C. Navin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Navin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Navin. The network helps show where Mark C. Navin may publish in the future.

Co-authorship network of co-authors of Mark C. Navin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Navin. A scholar is included among the top collaborators of Mark C. Navin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Navin. Mark C. Navin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Navin, Mark C. & Lainie Friedman Ross. (2025). America’s Vaccine Policy Whiplash—Finding the Way Forward. JAMA. 334(21). 1877–1877.
2.
Faust, Russell A., et al.. (2024). Challenging the ’acceptable option’: Public health’s advocacy for continued care in the case of pediatric vaccine refusal. Vaccine. 42(21). 126144–126144. 1 indexed citations
3.
Wasserman, Jason Adam, et al.. (2024). Pediatric Assent in Clinical Practice: A Critical Scoping Review. AJOB Empirical Bioethics. 15(4). 336–346. 1 indexed citations
4.
Navin, Mark C., et al.. (2024). Principled Conscientious Provision: Referral Symmetry and Its Implications for Protecting Secular Conscience. The Hastings Center Report. 54(4). 3–10.
5.
Attwell, Katie, et al.. (2024). Policy Feedback and the Politics of Childhood Vaccine Mandates: Conflict and Change in California, 2012–2019. Journal of Health Politics Policy and Law. 49(6). 1075–1110. 2 indexed citations
6.
Wasserman, Jason Adam, et al.. (2023). It’s Worth What You Can Sell It for: A Survey of Employment and Compensation Models for Clinical Ethicists. HEC Forum. 36(3). 405–420. 2 indexed citations
7.
Laventhal, Naomi, et al.. (2023). Ethics of age de-escalation in pediatric vaccine trials: Attending to the case of COVID-19. Vaccine. 41(9). 1584–1588. 2 indexed citations
8.
Navin, Mark C., Lindsay Oberleitner, Victoria C. Lucia, et al.. (2022). COVID-19 Vaccine Hesitancy Among Healthcare Personnel Who Generally Accept Vaccines. Journal of Community Health. 47(3). 519–529. 18 indexed citations
9.
Navin, Mark C., et al.. (2021). Three Kinds of Decision-Making Capacity for Refusing Medical Interventions. The American Journal of Bioethics. 22(11). 73–83. 6 indexed citations
10.
Navin, Mark C., et al.. (2021). US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates. JAMA. 327(2). 178–178. 9 indexed citations
11.
Quinn, Thomas J., Tracey E. Wilson, Mark C. Navin, et al.. (2021). Ethical Allocation of Proton Therapy and the Insurance Review Process. Practical Radiation Oncology. 11(5). e449–e458. 1 indexed citations
12.
Navin, Mark C., et al.. (2021). The capacity to designate a surrogate is distinct from decisional capacity: normative and empirical considerations. Journal of Medical Ethics. 48(3). medethics–2020. 3 indexed citations
13.
Navin, Mark C. & Margie Danchin. (2020). Vaccine mandates in the US and Australia: balancing benefits and burdens for children and physicians. Vaccine. 38(51). 8075–8077. 1 indexed citations
14.
Navin, Mark C., et al.. (2019). Perspectives of public health nurses on the ethics of mandated vaccine education. Nursing Outlook. 68(1). 62–72. 6 indexed citations
15.
Navin, Mark C., et al.. (2019). Vaccine Education, Reasons for Refusal, and Vaccination Behavior. American Journal of Preventive Medicine. 56(3). 359–367. 37 indexed citations
16.
Navin, Mark C., et al.. (2018). The evolution of immunization waiver education in Michigan: A qualitative study of vaccine educators. Vaccine. 36(13). 1751–1756. 16 indexed citations
17.
Sarathchandra, Dilshani, Mark C. Navin, Mark A. Largent, & Aaron M. McCright. (2018). A survey instrument for measuring vaccine acceptance. Preventive Medicine. 109. 1–7. 107 indexed citations
18.
Navin, Mark C.. (2016). The Ethics of Vaccination Nudges in Pediatric Practice. HEC Forum. 29(1). 43–57. 18 indexed citations
19.
Navin, Mark C.. (2013). Resisting Moral Permissiveness about Vaccine Refusal. Public Affairs Quarterly. 27(1). 9 indexed citations
20.
Navin, Mark C.. (2013). Competing Epistemic Spaces. Social Theory and Practice. 39(2). 241–264. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026